Glipizide

Product NDC: 59651-268
Requested package NDC: 59651-268-71
11-digit product format: 596510268
Labeler code: 59651
Product ID: 59651-268_17329bb9-0057-451a-8621-d6319d8939bd
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glipizide
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA206928
Marketing category: ANDA
Marketing start: 2017-05-12
Marketing end: 0000-00-00
Substance: GLIPIZIDE
Active strength: 3 mg/1
Pharmacologic classes: Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished package	package	59651-268	59651-268-71	UNFINISHED	Active or certified unfinished drug listing		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 19 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	`4bd3596a7b87…`	`5c64c6f6865f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A206928-001	GLIPIZIDE	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12
A206928-002	GLIPIZIDE	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12
A206928-003	GLIPIZIDE	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A206928-001	AB
A206928-002	AB
A206928-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206928-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206928-003	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206928-001	GLIPIZIDE	2.5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2017-05-12	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A206928-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206928-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206928-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206928-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206928-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206928-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206928-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206928-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206928-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206928-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206928-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206928-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206928-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206928-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206928-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206928-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206928-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206928-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206928-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206928-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206928-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206928-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206928-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206928-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206928-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206928-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206928-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206928-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206928-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206928-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206928-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206928-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206928-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206928-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206928-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206928-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206928-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206928-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206928-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206928-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: No
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GLIPIZIDE	2.5 mg/1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09	Product name	2	20250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5	Product name	5	20180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776a	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59651-268-30	EA - Each	59651-268	4aea6306-5907-4bbe-8aca-2b6b592f2760	1	2019-04-11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59651-268	GLIPIZIDE TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED]	6	Legacy NDC	20230606_9ace98c0-1115-4157-b611-fee4c915a8bf.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glipizide	GLIPIZIDE	St. Mary's Medical Park Pharmacy	1b2ef6e2-5e7c-761e-e063-6294a90addd0	2026-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	REMEDYREPACK INC.	0df8f606-97b3-463c-a132-338cf4630a71	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	St. Mary's Medical Park Pharmacy	0ccc17ca-fff8-0449-e063-6294a90af36d	2026-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	Bryant Ranch Prepack	2aa01a7e-a703-426f-9cd3-70b88d0a8e7f	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	Bryant Ranch Prepack	ceb86ebb-d00a-4261-90ad-8751e799d93c	2026-04-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	Bryant Ranch Prepack	4afa67b2-7f86-4189-93a5-6a605f74540d	2026-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	REMEDYREPACK INC.	667dd68a-d3e7-4b50-bd0a-d17783a090d5	2026-03-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	Aurobindo Pharma Limited	84794a52-b717-488c-8533-6425c83d405f	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	Northwind Health Company, LLC	0a1e1152-ade7-2092-e063-6394a90a99e7	2025-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	Northwind Health Company, LLC	0effd04d-172c-5d8c-e063-6294a90a93f4	2025-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	American Health Packaging	aaf029d3-027e-4ae8-8ec5-3a4c16f9bd28	2025-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	A-S Medication Solutions	08b01608-73c2-45e0-8de4-c6c401261152	2023-10-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928
Glipizide	GLIPIZIDE	A-S Medication Solutions	695c178f-77f0-451e-b718-72b65e495b7e	2023-10-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206928 application number: ANDA206928

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X7WDT95N5C	GLIPIZIDE	29094-61-9	GLIPIZIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Status
59651-268-71	59651026871	7000 TABLET, EXTENDED RELEASE in 1 BAG (59651-268-71)	12-MAY-17	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glipizide	REMEDYREPACK INC.	2024-03-01	HUMAN PRESCRIPTION DRUG LABEL	5
Glipizide	American Health Packaging	2023-07-17	HUMAN PRESCRIPTION DRUG LABEL	4
Glipizide	Aurobindo Pharma Limited	2023-06-03	Human Prescription Drug Label	6